An experimental drug in early development for
aggressive brain tumors can cross the
blood - brain tumor barrier,
kill tumor cells and block the growth of tumor
blood vessels, according to a study led by researchers at the Ohio State University Comprehensive
Cancer Center — Arthur G. James
Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James).